Evidence map›Paper›PMID 39921829›Full record

ArticleDermatology and therapy2025

CDKN2A Mutation: A Patient's and Physician's Experience.

Yaelle Shaked, Alyssa Swearingen, Tracey N Liebman

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Dermatology and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yaelle ShakedRonald O. Perelman Department of Dermatology, NYU Langone Health, New York University Grossman School of Medicine, 240 E 38th St, 11th Floor, New York, NY, 10016, USA.
Alyssa SwearingenRonald O. Perelman Department of Dermatology, NYU Langone Health, New York University Grossman School of Medicine, 240 E 38th St, 11th Floor, New York, NY, 10016, USA.
Tracey N LiebmanRonald O. Perelman Department of Dermatology, NYU Langone Health, New York University Grossman School of Medicine, 240 E 38th St, 11th Floor, New York, NY, 10016, USA. Tracey.Liebman@nyulangone.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article discusses both the patient's and physician's perspective on the CDKN2A mutation. After an intriguing interview with the patient, the author writes about the patient's feelings, thoughts, and overall experience when he was diagnosed with the CDKN2A mutation. The patient's story discusses what prompted the patient to get tested for the mutation and how the diagnosis later impacted his life and that of his family. The author describes the clinical relevance of the CDKN2A mutation and the current guidelines for testing. The author highlights the need to recognize patients with familial melanomas as high risk and educate the patient on the importance of routine dermatological surveillance.

Indexed as

CDKN2ADermatological surveillanceEarly detectionGuidelinesMelanomaPancreatic cancerSelf-skin examSkin awareness

Identifiers

PMID39921829
PMCPMC11832995

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.